Taking a Bite Out of a 9.5% ORIF Re-Operation Rate

“X-rays supporting our testing at GCMI and T3 Labs clearly showed where the device engaged and the tip aligned at the bone level. This kind of evidence is important for our design history file, something that should make our regulatory journey and overall commercialization pathway more efficient.”

Let’s Talk Innovation, Including Preclinical for Artificial Organ Technologies, at ASAIO 2023

Evaluating your new artificial organ technology’s readiness for preclinical work or just want to get together to talk about the latest in preclinical testing, bioskills training or medtech innovation across the board? Connect with GCMI and T3 Labs at ASAIO 2023. At GCMI, medtech and medical device innovation are at the core of our efforts…

Preclinical Implications for Existing, and New Circulatory Assist Devices

The National Center for Biotechnology Information describes mechanical circulatory assist devices as, “commonly used in the treatment of severe heart failure as bridges to cardiac transplant, as destination therapy for patients who are not transplant candidates, and as bridges to recovery and “decision-making.” These devices, which can be used to support the left or right…

Center for Medtech Excellence Shares 2023, 2024 Cohort Dates

Medtech startups or established businesses looking to scale are encouraged to apply for one of the upcoming 16-week accelerator cohorts at the Center for MedTech Excellence. Launched in September 2022, the Center for Medtech Excellence catalyzes the development and commercialization of breakthrough biotechnology, medical devices, life science and therapeutic innovations. Primary areas of focus include…

Funding Support for GT Innovators and Researchers with Promising Medical Technologies

Funding varies in specific levels from fiscal year to fiscal year, specifically supports projects with high potential for successful commercialization, follow on funding and improved patient outcomes. Projects are selected by GCMI leadership in consultation with the board of directors. These funds are not for staff / salary or lab support. 

You’re a researcher or engineer who has found a solid unmet clinical need. Excellent! Now the rigorous work begins.

You’re a researcher or engineer who has found a clinician with a strong unmet clinical need your technology might solve.   Outstanding! Too many technologies go looking for problems to solve instead of finding the clinically stated problem first and fitting your technology to meet it in a way that truly works in the clinical…

Moving Beyond Improvisation. Solving a High Volume, High Value Unmet Clinical Need to Advance Patient Care

A “Catheter Gripping Tool” solving an unmet need as GCMI’s grows its roster of collaborative medtech innovations with the Children’s Mercy Kansas City Center for Pediatric Innovation.   Human beings are generally good at improvisation. Assembly calls for a 10mm socket? Try this handy crescent wrench right here and maybe it will do. What happened…

GCMI CEO Sherry Farrugia Named 2023 Recipient of the Center for Global Health Innovation’s Highest Honor, the Industry Growth Award.

The Center for Global Health Innovation (CGHI) recently announced the winners of its 2023 Golden Helix Awards. Congratulations to GCMI’s CEO, Sherry Farrugia, recipient of the 2023 Industry Growth Awards for her impact on the life sciences industry in the state. The Industry Growth Awards are the highest honors bestowed each year by CGHI.  …

Ortho Innovators: Advance Your Technology, at Any Phase in Its Pathway, by Connecting with GCMI at ORS 2023

If you’re attending ORS 2023 and have a new orthopedic technology in development, including preclinical work that may be on your product development horizon, you have a wonderful chance to connect with our Director of Scientific Affairs Evan Goldberg onsite.   GCMI is the U.S. proving ground for global medical innovation. Our mission is to…